{"id":874322,"date":"2025-08-12T04:03:10","date_gmt":"2025-08-12T08:03:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\/"},"modified":"2025-08-12T04:03:10","modified_gmt":"2025-08-12T08:03:10","slug":"oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\/","title":{"rendered":"Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ZUG, Switzerland, Aug.  12, 2025  (GLOBE NEWSWIRE) &#8212; Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (\u201cOculis\u201d), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic conditions with significant unmet medical needs, today announced that Oculis\u2019 management will be participating in the H.C. Wainwright 5<sup>th<\/sup> Annual Ophthalmology Virtual Conference on August 13, 2025.<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt;text-align:justify\">Sylvia Cheung, Oculis\u2019 Chief Financial Officer, will be presenting a corporate update which will be made available for replay via webcast at 7:00am ET.<\/li>\n<li style=\"margin-bottom:8pt;text-align:justify\">Snehal Shah, Oculis\u2019 President of R&amp;D, will be participating in a live panel discussion from 11:00am to 12:00pm ET, on Pivotal-Stage Assets for Retinal Disorders. The panel discussion will also be made available via webcast for replay.<\/li>\n<\/ul>\n<p align=\"justify\">Links to access the corporate update presentation and the panel discussion will be posted to Oculis\u2019 website on the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tcTYU9WmfmepOCPVrC92MZL233c_CCjnFWwA5lnwq0xtAX4DJiHBZDt_7LzZWKZIZ23OYVhPed5TTsVDLFFdS75rkLFC28DHzgttuuLMwnUBvFSZQjL5XSv8rawD-YgKfNlAV9vZ4lE5RA-In7OIw8YuhSsI0pksFvZNh_27iz806oP3Rm0ZZS84EpASht7NWbu10NN0KAWUvH2HaeagRhYm6ErnGdfAIzz5AqKTzIkDoVFXxLorQ5EnEri6AIUkm5whaPtXYvHzoamSn7fSi9NyM4j_8mIh-YIp8p9wd3qN0Hrugq1KzFbU4qFHrN2n\" rel=\"nofollow\" target=\"_blank\">Events &amp; Presentation<\/a>\u00a0page under the Investors &amp; Media section.<\/p>\n<p align=\"justify\">\n        <strong>About Oculis<\/strong>\n      <\/p>\n<p align=\"justify\">Oculis is a global biopharmaceutical company (Nasdaq: OCS; XICE: OCS) focused on innovations addressing ophthalmic and neuro-ophthalmic conditions with significant unmet medical needs. Oculis\u2019 highly differentiated late-stage clinical pipeline includes three core product candidates: OCS-01, an eye drop in pivotal registration studies, aiming to become the first non-invasive topical treatment for diabetic macular edema; Privosegtor (OCS-05), a neuroprotective candidate in Phase 2 for acute optic neuritis, with potentially broad clinical applications in various neuro-ophthalmic and neurological diseases; and Licaminlimab (OCS-02), a novel topical anti-TNF\u03b1 in Phase 2, being developed with a genotype-based approach to drive personalized medicine in dry eye disease (DED). Headquartered in Switzerland with operations in the U.S. and Iceland, Oculis is led by an experienced management team with a successful track record and supported by leading international healthcare investors.<\/p>\n<p align=\"justify\">For more information, please visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8gCXwEh38ACNspuzGdLScjGM4UKL3Z0SXs0zO_IvvCardsv3wWLNdI2YuUuTopSChMy0zVvk2Ss8MVq6ARSNjw==\" rel=\"nofollow\" target=\"_blank\">www.oculis.com<\/a><\/p>\n<p align=\"left\">\n        <strong>Oculis Contacts<\/strong><br \/>\n        <br \/>Ms. Sylvia Cheung, CFO<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lBoqCZ8Atqd5wfHlJU61ICMwKkisLFSTdzueD_p_xRnm2uKUfEHj8369ZsQguCAanmBbIDDXXD2MPvxPVFAxP8tj8pYv9oQfHaJ3PNONpus8KOVgUM6nkA1N23JbSnyG\" rel=\"nofollow\" target=\"_blank\">sylvia.cheung@oculis.com<\/a><\/p>\n<p align=\"left\">\n        <strong>Investor Relations <\/strong><br \/>\n        <br \/>LifeSci Advisors<br \/>Corey Davis, Ph.D.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Lwl-SvT-tzKagyGUx6UxDewEj6goXvW61kqv0n7KA3AXHFUiDFcIgYm3Lnp39zbnQ6MSJw6voaOZcRBs9LClKvkVhYQzHiWUJlTTUVjIsZKDWD0tZOaVTU-WL_W_vQUI\" rel=\"nofollow\" target=\"_blank\">cdavis@lifesciadvisors.com<\/a><\/p>\n<p align=\"left\">\n        <strong>Media Relations<\/strong><br \/>\n        <br \/>ICR Healthcare<br \/>Amber Fennell \/ David Daley \/ Sean Leous<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=25UKjQiQvp2LDYBNUtwzAFwof-CX30HCXNUoKQCivbjDFWlaUVn8oImQmEGCC1r882dThCZheWHfKjGti-RYxahAn7FmJX4m5LVO7bDkZZNir4LwtaI1kpd49x06Gi9M\" rel=\"nofollow\" target=\"_blank\">oculis@icrhealthcare.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyMjQxNiM0MDIxOTY4MDkjMjE4OTAyMw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/YjRmMDYwNWMtOTdlYi00YzY1LTk2M2ItOTY1M2ZiZTg4ZGRlLTEyMDA1NzYtMjAyNS0wOC0xMi1lbg==\/tiny\/Oculis-Holding-AG.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ZUG, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) &#8212; Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (\u201cOculis\u201d), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic conditions with significant unmet medical needs, today announced that Oculis\u2019 management will be participating in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference on August 13, 2025. Sylvia Cheung, Oculis\u2019 Chief Financial Officer, will be presenting a corporate update which will be made available for replay via webcast at 7:00am ET. Snehal Shah, Oculis\u2019 President of R&amp;D, will be participating in a live panel discussion from 11:00am to 12:00pm ET, on Pivotal-Stage Assets for Retinal Disorders. The panel discussion will also be made available via webcast for replay. Links to access the corporate &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-874322","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ZUG, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) &#8212; Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (\u201cOculis\u201d), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic conditions with significant unmet medical needs, today announced that Oculis\u2019 management will be participating in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference on August 13, 2025. Sylvia Cheung, Oculis\u2019 Chief Financial Officer, will be presenting a corporate update which will be made available for replay via webcast at 7:00am ET. Snehal Shah, Oculis\u2019 President of R&amp;D, will be participating in a live panel discussion from 11:00am to 12:00pm ET, on Pivotal-Stage Assets for Retinal Disorders. The panel discussion will also be made available via webcast for replay. Links to access the corporate &hellip; Continue reading &quot;Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-12T08:03:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyMjQxNiM0MDIxOTY4MDkjMjE4OTAyMw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference\",\"datePublished\":\"2025-08-12T08:03:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\\\/\"},\"wordCount\":329,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyMjQxNiM0MDIxOTY4MDkjMjE4OTAyMw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\\\/\",\"name\":\"Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyMjQxNiM0MDIxOTY4MDkjMjE4OTAyMw==\",\"datePublished\":\"2025-08-12T08:03:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyMjQxNiM0MDIxOTY4MDkjMjE4OTAyMw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyMjQxNiM0MDIxOTY4MDkjMjE4OTAyMw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\/","og_locale":"en_US","og_type":"article","og_title":"Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - Market Newsdesk","og_description":"ZUG, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) &#8212; Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (\u201cOculis\u201d), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic conditions with significant unmet medical needs, today announced that Oculis\u2019 management will be participating in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference on August 13, 2025. Sylvia Cheung, Oculis\u2019 Chief Financial Officer, will be presenting a corporate update which will be made available for replay via webcast at 7:00am ET. Snehal Shah, Oculis\u2019 President of R&amp;D, will be participating in a live panel discussion from 11:00am to 12:00pm ET, on Pivotal-Stage Assets for Retinal Disorders. The panel discussion will also be made available via webcast for replay. Links to access the corporate &hellip; Continue reading \"Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-12T08:03:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyMjQxNiM0MDIxOTY4MDkjMjE4OTAyMw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference","datePublished":"2025-08-12T08:03:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\/"},"wordCount":329,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyMjQxNiM0MDIxOTY4MDkjMjE4OTAyMw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\/","name":"Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyMjQxNiM0MDIxOTY4MDkjMjE4OTAyMw==","datePublished":"2025-08-12T08:03:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyMjQxNiM0MDIxOTY4MDkjMjE4OTAyMw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyMjQxNiM0MDIxOTY4MDkjMjE4OTAyMw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-participate-in-upcoming-h-c-wainwright-5th-annual-ophthalmology-virtual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/874322","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=874322"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/874322\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=874322"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=874322"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=874322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}